[1] 裴桂华, 殷复粉, 王宁, 等. Hsa-miR-6841-3p对宫颈癌细胞系Caski增殖及侵袭转移的影响[J]. 现代妇产科进展, 2016, 25(8): 566-570. DOI: 10.13283/j.cnki.xdfckjz.2016.08.002.
[2] 胡倩倩, 孙锐, 严浩, 等. MiR634通过mTOR通路抑制宫颈癌细胞c4-1、caski增殖并促进其凋亡的研究[J]. 中国免疫学杂志, 2016, 32(11): 1610-1613, 1620. DOI: 10.3969/j.issn.1000-484X.2016.11.010.
[3] 姜亚运, 王婷, 王晋蜀, 等. 过表达β联蛋白和T细胞因子抑制物(ICAT)促进人宫颈癌Caski细胞的增殖和迁移[J]. 细胞与分子免疫学杂志, 2016, 32(11): 1499-1502.
[4] 刘静, 余梦红, 张丛敏,等. 紫杉醇联合洛铂经介入栓塞给药化疗宫颈癌的临床观察[J]. 中国药房, 2017, 28(17): 2374-2377. DOI: 10.6039/j.issn.1001-0408.2017.17.19.
[5] 李凤虎, 杨飞月, 常建英, 等. 宫颈癌紫杉醇联合洛铂或顺铂新辅助序贯洛铂或顺铂同步化放疗多中心随机临床研究[J]. 中华肿瘤防治杂志, 2016, 23(16): 1090-1094. DOI: 10.3969/j.issn.1673-5269.2016.16.009.
[6] 肖晶晶, 郭奇桑, 王宪政, 等. TLR4/NO通路在高危型HPV阳性的子宫颈癌组织和细胞中的表达及意义[J]. 中华妇产科杂志, 2015, 50(1): 41-47. DOI: 10.3760/cma.j.issn.0529-567X.2015.01.010.
[7] Xu F, Cao M, Shi Q, et al. Integration of the fulllength HPV16 genome in cervical cancer and Caski and Siha cell lines and the possible ways of HPV integration[J]. Virus Genes, 2015, 50(2): 210-220. DOI: 10.1007/s11262-014-1164-7.
[8] Pei Z, Zeng J, Gao Y, et al. Oxymatrine inhibits the proliferation of CaSki cells via downregulating HPV16E7 expression[J]. Oncol Rep, 2016, 36(1): 291-298. DOI: 10.3892/or.2016.4800.
[9] Feng S, Yang Y, Lv J, et al. Valproic acid exhibits different cell growth arrest effect in three HPVpositive/negative cervical cancer cells and possibly via inducing Notch1 cleavage and E6 downregulation[J]. Int J Oncol, 2016, 49(1): 422-430. DOI: 10.3892/ijo.2016.3508.
[10] Kim YW, Chaturvedi PK, Chun SN, et al. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line[J]. Oncol Rep, 2015, 33(4): 1675-1682. DOI: 10.3892/or.2015.3760.
[11] Xie L, Huang J, Chen X, et al. Synthesis of rapamycin derivatives containing the triazole moiety used as potential mTORtargeted anticancer agents[J]. Arch Pharm (Weinheim), 2016, 349(6): 428-441. DOI: 10.1002/ardp.201500457.
[12] Li X, Ran L, Fang W, et al. Lobaplatin arrests cell cycle progression, induces apoptosis and alters the proteome in human cervical cancer cell line CaSki[J]. Biomed Pharmacother, 2014, 68(3): 291-297. DOI: 10.1016/j.biopha.2013.10.004.
[13] Kaufmann AM, Nieland J, Schinz M, et al. HPV16 L1E7 chimeric viruslike particles induce specific HLArestricted T cells in humans after in vitro vaccination[J]. Int J Cancer, 2001, 92(2): 285-293.
[14] Choo KB, Chen CM, Han CP, et al. Molecular analysis of cellular loci disrupted by papillomavirus 16 integration in cervical cancer: frequent viral integration in topologically destabilized and transcriptionally active chromosomal regions[J]. J Med Virol, 1996, 49(1): 15-22. DOI: 10.1002/(SICI)10969071(199605)49:1<15::AIDJMV3>3.0CO;2N.
[15] Munagala R, Aqil F, Jeyabalan J, et al. Tanshinone ⅡA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer[J]. Cancer Lett, 2015, 356(2 Pt B): 536546. DOI: 10.1016/j.canlet.2014.09.037. |